Amgen To Challenge Inclusion Of Oral ESRD Drugs With No I.V. Equivalent In Medicare Payment Bundle

All ESRD drugs, including those currently covered under Medicare Part D, would be paid for under the new proposed bundled payment for end stage renal disease drugs and services in Part B.